Generex Biotechnology Corporation (GNBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Generex Biotechnology Corporation (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. The company focuses on drug delivery system of large molecules in the areas of seasonal influenza virus, melanoma, ovarian cancer, HIV, HPV, allergy and Type I diabetes mellitus. It has a proprietary platform technology to deliver drugs into the human body through the oral cavity. The proprietary and proven advanced technology platform consists of buccal delivery technology and immunomedicines for the administration of formulations of large molecule drugs to the oral cavity.

Generex Biotechnology Corporation Key Recent Developments

Aug 13, 2013: Generex Announces Podium Presentation on Antigen Express Cancer Vaccine Strategy
Aug 12, 2013: Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board
Jul 23, 2013: Generex Confirms Conference Call with Members of the Antigen Express Scientific Advisory Board
Jul 12, 2013: Generex Announces Particulars of Conference Call with Members of the Antigen Express Scientific Advisory Board
Jul 08, 2013: Generex Announces Conference Call with Members of Generex Oral-lyn and Diabetes Program Team

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Generex Biotechnology Corporation (GNBT) - Financial and Strategic SWOT Analysis Review
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Generex Biotechnology Corporation - Key Facts 5
Generex Biotechnology Corporation - Key Employees 6
Generex Biotechnology Corporation - Key Employee Biographies 7
Generex Biotechnology Corporation - Major Products and Services 8
Generex Biotechnology Corporation - Pharmaceutical Pipeline Products Data 9
Generex Biotechnology Corporation, Pipeline Products by Therapy Area 9
Generex Biotechnology Corporation, Pipeline Products by Development Phase 10
Generex Biotechnology Corporation - History 12
Generex Biotechnology Corporation - Company Statement 15
Generex Biotechnology Corporation - Locations And Subsidiaries 17
Head Office 17
Other Locations and Subsidiaries 17
Section 2 - Company Analysis 18
Generex Biotechnology Corporation - Business Description 18
Generex Biotechnology Corporation - Corporate Strategy 19
Generex Biotechnology Corporation - SWOT Analysis 20
SWOT Analysis - Overview 20
Generex Biotechnology Corporation - Strengths 20
Strength - Robust Intellectual Property Portfolio 20
Strength - Buccal Delivery Technology 20
Strength - Sturdy Research and Development Activities 20
Generex Biotechnology Corporation - Weaknesses 21
Weakness - Legal Proceedings 21
Weakness - Dependence on Few Suppliers 21
Generex Biotechnology Corporation - Opportunities 21
Opportunity - Market Potential: Diabetes 21
Opportunity - Demographic Trends 21
Opportunity - Pipeline Products 21
Generex Biotechnology Corporation - Threats 22
Threat - Intense Competition 22
Threat - Stringent Government Regulations 22
Threat - Uncertain RandD Outcomes 22
Generex Biotechnology Corporation - Key Competitors 23
Section 3 - Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 24
Performance Chart 26
Financial Performance 26
Financial Ratios - Interim Ratios 27
Financial Ratios - Ratio Charts 28
Section 4 - Company's Lifesciences Financial Deals and Alliances 29
Generex Biotechnology Corporation, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 29
Generex Biotechnology Corporation, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 30
Generex Biotechnology Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 31
Generex Biotechnology Corporation, Medical Equipment, Deals By Type, 2008 to YTD 2014 32
Generex Biotechnology Corporation, Recent Deals Summary 33
Section 5 - Company's Recent Developments 34
Generex Biotechnology Corporation, Recent Developments 34
Aug 13, 2013: Generex Announces Podium Presentation on Antigen Express Cancer Vaccine Strategy 34
Aug 12, 2013: Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board 34
Aug 12, 2013: Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board 35
Jul 23, 2013: Generex Confirms Conference Call with Members of the Antigen Express Scientific Advisory Board 35
Jul 12, 2013: Generex Announces Particulars of Conference Call with Members of the Antigen Express Scientific Advisory Board 36
Jul 08, 2013: Generex Announces Conference Call with Members of Generex Oral-lyn and Diabetes Program Team 37
Jul 01, 2013: Generex Announces Conference Call with Members of the Antigen Express Scientific Advisory Board 37
Jun 10, 2013: Generex Biotechnology Reports Q3 Fiscal 2013 Results 37
Apr 25, 2013: Biohit Announces Q1 2013 Results 38
Mar 11, 2013: Generex Biotechnology Reports Q2 Fiscal 2013 Results 41
Section 6 - Appendix 43
Methodology 43
Ratio Definitions 43
About GlobalData 47
Contact Us 47
Disclaimer 47



List of Tables

Generex Biotechnology Corporation, Key Facts 5
Generex Biotechnology Corporation, Key Employees 6
Generex Biotechnology Corporation, Key Employee Biographies 7
Generex Biotechnology Corporation, Major Products and Services 8
Generex Biotechnology Corporation, Number of Pipeline Products by Therapy Area 9
Generex Biotechnology Corporation, Number of Pipeline Products by Development Stage 10
Generex Biotechnology Corporation, Pipeline Products By Therapy Area and Development Phase 11
Generex Biotechnology Corporation, History 12
Generex Biotechnology Corporation, Subsidiaries 17
Generex Biotechnology Corporation, Key Competitors 23
Generex Biotechnology Corporation, Ratios based on current share price 24
Generex Biotechnology Corporation, Annual Ratios 24
Generex Biotechnology Corporation, Interim Ratios 27
Generex Biotechnology Corporation, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 29
Generex Biotechnology Corporation, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 30
Generex Biotechnology Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 31
Generex Biotechnology Corporation, Medical Equipment, Deals By Type, 2008 to YTD 2014 32
Generex Biotechnology Corporation, Recent Deals Summary 33
Currency Codes 43
Capital Market Ratios 43
Equity Ratios 44
Profitability Ratios 44
Cost Ratios 45
Liquidity Ratios 45
Leverage Ratios 46
Efficiency Ratios 46



List of Figures

Generex Biotechnology Corporation, Pipeline Products by Therapy Area 9
Generex Biotechnology Corporation, Pipeline Products by Development Phase 10
Generex Biotechnology Corporation, Performance Chart (2009 - 2013) 26
Generex Biotechnology Corporation, Ratio Charts 28
Generex Biotechnology Corporation, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 29
Generex Biotechnology Corporation, Pharmaceuticals and Healthcare, Deals by Type, 2008 to YTD 2014 30
Generex Biotechnology Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 31
Generex Biotechnology Corporation, Medical Equipment, Deals by Type, 2008 to YTD 2014 32

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

H1N1 Infection - Pipeline Review, H1 2015

H1N1 Infection - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • March 2015
  • by Global Markets Direct

H1N1 Infection - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘H1N1 Infection - Pipeline Review, H1 2015’, provides an overview of the H1N1 Infection’s therapeutic pipeline. This report ...

Shanghai Zerun Biotechnology Co., Ltd. - Product Pipeline Review - 2015

Shanghai Zerun Biotechnology Co., Ltd. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

Shanghai Zerun Biotechnology Co., Ltd. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Shanghai Zerun Biotechnology Co., Ltd. - Product Pipeline Review - 2015’, provides an overview ...

Iris BioTechnologies Inc. (IRSB) - Financial and Strategic SWOT Analysis Review

Iris BioTechnologies Inc. (IRSB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Iris BioTechnologies Inc. (Iris BioTechnologies) is a biotechnology company. It focuses on the development and commercialization of Nano-Biochips and an artificial intelligence system, which assists ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.